[Effect of cyclic AMP on the metabolism of low density lipoproteins and cholesterol in fibroblasts of normal subjects and subjects with homozygous type familial IIa hypercholesterolemia].
D002784:Cholesterol / Q000096:biosynthesis / Q000378:metabolism*; D008078:Cholesterol, LDL; D000242:Cyclic AMP / Q000494:pharmacology* / Q000627:therapeutic use; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D011956:Receptors, Cell Surface; D011973:Receptors, LDL
D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D002784:Cholesterol; D000242:Cyclic AMP
Effets de l'adenylate cyclique (cAMP) sur le métabolisme des lipoprotéines de basse densité (LDL) et du cholestérol dans les fibroblastes de sujets normaux et de sujets atteints d'hypercholestérolémie familiale type IIa homozygotes.